TALI Digital Limited (TD1)

 NULL
   
  • 52 Week High: NULL
  • 52 Week Low: $0.00
  • Currency: Australian Dollars
  • Shares Issued: 449.31m

TD1 Overview

Avexa Limited is a Melbourne-based biotechnology company with a focus on research and development of drugs for the treatment of infectious diseases. The company’s lead program is apricitabine (ATC), an anti-HIV drug.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn n/a
ROCE n/a
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue n/a
PBT n/a
EPS n/a
DPS n/a

TD1 Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-06 n/a (17.83) (9.34)¢ n/a n/a n/a n/a 0.0%
30-Jun-07 n/a (15.22) (4.48)¢ n/a n/a n/a n/a 0.0%
30-Jun-08 n/a (36.09) (7.91)¢ n/a n/a n/a n/a 0.0%
30-Jun-09 n/a (36.22) (7.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-10 n/a (41.49) (5.40)¢ n/a n/a n/a n/a 0.0%

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

TD1 Market Data

Currency Australian Dollars
% Change 0.00 %
52 Week High NULL
52 Week Low $0.00
Shares Issued 449.31m

Top of Page